Contents

Current Pharmaceutical Biotechnology, Volume 14 - Number 5

Foreword (“New Targets and New Drugs: from in silico Planning to in vivo Testing”)

, 14(5): 475 - 476

Giovanni Maga


DOI: 10.2174/138920101405131111103331




Allosteric Inhibitors of Bcr-Abl: Towards Novel Myristate-Pocket Binders

, 14(5): 477 - 487

Marco Radi, Silvia Schenone and Maurizio Botta


DOI: 10.2174/138920101405131111103750




Therapeutic Genes for Anti-HIV/AIDS Gene Therapy

, 14(5): 488 - 500

Chiara Bovolenta, Simona Porcellini and Luca Alberici


DOI: 10.2174/138920101405131111104009




Peptides as Drugs: From Screening to Application

, 14(5): 501 - 512

Ursula Dietrich, Ralf Dürr and Joachim Koch


DOI: 10.2174/13892010113149990205




Capsid Assembly as a Point of Intervention for Novel Anti-viral Therapeutics

, 14(5): 513 - 523

Vishwanath R. Lingappa, Clarence R. Hurt and Edward Garvey


DOI: 10.2174/13892010113149990201




Poly(ADP-ribosylation) and Neoplastic Transformation: Effect of PARP Inhibitors

, 14(5): 524 - 536

Francesca Donà, Ilaria Chiodi, Cristina Belgiovine, Tatiana Raineri, Roberta Ricotti, Chiara Mondello and Anna Ivana Scovassi


DOI: 10.2174/138920101405131111104642




X-ray Crystallography as a Tool for Mechanism-of-Action Studies and Drug Discovery

, 14(5): 537 - 550

Eric Ennifar


DOI: 10.2174/138920101405131111104824




The Power of Enzyme Kinetics in the Drug Development Process

, 14(5): 551 - 560

Alberta Samuele, Emmanuele Crespan, Anna Garbelli, Laura Bavagnoli and Giovanni Maga


DOI: 10.2174/138920101405131111105023




Simple and General Criterion for “in silico” Screening of Candidate HIV Drugs

, 14(5): 561 - 569

Nevena Veljkovic, Sanja Glisic, Jelena Prljic, Vladimir Perovic and Veljko Veljkovic


DOI: 10.2174/138920101405131111105301




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science